Prestige Consumer Healthcare Inc
NYSE:PBH

Watchlist Manager
Prestige Consumer Healthcare Inc Logo
Prestige Consumer Healthcare Inc
NYSE:PBH
Watchlist
Price: 60.31 USD -0.84% Market Closed
Market Cap: 2.9B USD

Prestige Consumer Healthcare Inc
Cash & Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Prestige Consumer Healthcare Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Prestige Consumer Healthcare Inc
NYSE:PBH
Cash & Cash Equivalents
$119.1m
CAGR 3-Years
41%
CAGR 5-Years
35%
CAGR 10-Years
18%
Johnson & Johnson
NYSE:JNJ
Cash & Cash Equivalents
$8.4B
CAGR 3-Years
15%
CAGR 5-Years
-5%
CAGR 10-Years
-5%
Bristol-Myers Squibb Co
NYSE:BMY
Cash & Cash Equivalents
$15.7B
CAGR 3-Years
27%
CAGR 5-Years
-4%
CAGR 10-Years
15%
Pfizer Inc
NYSE:PFE
Cash & Cash Equivalents
$1.3B
CAGR 3-Years
1%
CAGR 5-Years
-3%
CAGR 10-Years
-8%
Merck & Co Inc
NYSE:MRK
Cash & Cash Equivalents
$18.2B
CAGR 3-Years
18%
CAGR 5-Years
20%
CAGR 10-Years
9%
Eli Lilly and Co
NYSE:LLY
Cash & Cash Equivalents
$9.8B
CAGR 3-Years
55%
CAGR 5-Years
22%
CAGR 10-Years
12%
No Stocks Found

Prestige Consumer Healthcare Inc
Glance View

Prestige Consumer Healthcare Inc. has carved out its niche in the competitive realm of over-the-counter healthcare products with a distinct flair. Born out of a series of insightful acquisitions and strategic brand cultivations, the company has crafted a portfolio that caters to a broad spectrum of consumer health needs. It offers an expansive range of products, from well-known pain relievers and eye care items to gastrointestinal treatments and women’s health solutions. The cornerstone of Prestige's success lies in its acute understanding of consumer demand and its agile response to market trends. By developing and acquiring brands that are established household names—such as Clear Eyes, Chloraseptic, and Dramamine—the firm has effectively secured a reliable revenue stream. Each brand, while under the corporate umbrella of Prestige, thrives on its ability to resonate with consumers who seek trustworthy, easily accessible remedies. Central to Prestige’s business model is its adeptness at maintaining and enhancing brand equity. Through a blend of focused marketing strategies and disciplined cost management, the company ensures consistent visibility and availability of its products across key retail channels, including mass merchandisers, drug retailers, and e-commerce. Prestige's skillful navigation of the marketplace allows it to capitalize on scale economies and maintain healthy margins. Each product in its portfolio is not only a testament to its commitment to quality and efficacy but also to its strategic foresight in addressing the ever-evolving healthcare challenges faced by consumers. In essence, Prestige Consumer Healthcare Inc. thrives by blending astute brand management with a keen focus on consumer health trends, ensuring its position as a formidable player in the healthcare industry.

PBH Intrinsic Value
75.74 USD
Undervaluation 20%
Intrinsic Value
Price

See Also

What is Prestige Consumer Healthcare Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
119.1m USD

Based on the financial report for Sep 30, 2025, Prestige Consumer Healthcare Inc's Cash & Cash Equivalents amounts to 119.1m USD.

What is Prestige Consumer Healthcare Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
18%

Over the last year, the Cash & Cash Equivalents growth was 131%. The average annual Cash & Cash Equivalents growth rates for Prestige Consumer Healthcare Inc have been 41% over the past three years , 35% over the past five years , and 18% over the past ten years .

Back to Top